Free Trial

Wellington Management Group LLP Buys Shares of 461,333 Ryan Specialty Holdings, Inc. (NYSE:RYAN)

Ryan Specialty logo with Finance background

Wellington Management Group LLP bought a new position in shares of Ryan Specialty Holdings, Inc. (NYSE:RYAN - Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm bought 461,333 shares of the company's stock, valued at approximately $29,599,000. Wellington Management Group LLP owned approximately 0.18% of Ryan Specialty as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds and other institutional investors also recently modified their holdings of the company. KBC Group NV boosted its holdings in Ryan Specialty by 1,803.6% in the fourth quarter. KBC Group NV now owns 46,181 shares of the company's stock valued at $2,963,000 after acquiring an additional 43,755 shares during the last quarter. Mutual of America Capital Management LLC raised its position in shares of Ryan Specialty by 1.7% during the fourth quarter. Mutual of America Capital Management LLC now owns 56,203 shares of the company's stock worth $3,606,000 after purchasing an additional 914 shares during the period. Truist Financial Corp raised its position in shares of Ryan Specialty by 7.2% during the fourth quarter. Truist Financial Corp now owns 5,688 shares of the company's stock worth $365,000 after purchasing an additional 381 shares during the period. Stephens Inc. AR raised its position in shares of Ryan Specialty by 33.9% during the fourth quarter. Stephens Inc. AR now owns 5,836 shares of the company's stock worth $374,000 after purchasing an additional 1,477 shares during the period. Finally, CIBC Private Wealth Group LLC raised its position in shares of Ryan Specialty by 6,911.0% during the fourth quarter. CIBC Private Wealth Group LLC now owns 785,928 shares of the company's stock worth $48,036,000 after purchasing an additional 774,718 shares during the period. Institutional investors and hedge funds own 84.82% of the company's stock.

Insider Activity at Ryan Specialty

In other Ryan Specialty news, EVP Brendan Martin Mulshine sold 30,000 shares of the company's stock in a transaction dated Friday, March 14th. The stock was sold at an average price of $69.30, for a total value of $2,079,000.00. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. 52.21% of the stock is owned by company insiders.

Analyst Upgrades and Downgrades

A number of research firms recently commented on RYAN. The Goldman Sachs Group raised Ryan Specialty from a "neutral" rating to a "buy" rating and increased their price target for the company from $74.00 to $81.00 in a research report on Tuesday, May 13th. Barclays cut their target price on Ryan Specialty from $88.00 to $83.00 and set an "overweight" rating for the company in a research note on Friday, April 11th. UBS Group raised their target price on Ryan Specialty from $82.00 to $84.00 and gave the stock a "buy" rating in a research note on Wednesday, February 26th. Royal Bank of Canada dropped their price target on Ryan Specialty from $73.00 to $72.00 and set a "sector perform" rating for the company in a research report on Friday, February 21st. Finally, Wells Fargo & Company dropped their price target on Ryan Specialty from $69.00 to $66.00 and set an "equal weight" rating for the company in a research report on Thursday, April 10th. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating and eight have issued a buy rating to the company's stock. According to data from MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and a consensus price target of $75.58.

Check Out Our Latest Analysis on Ryan Specialty

Ryan Specialty Trading Down 0.1%

Ryan Specialty stock traded down $0.04 during trading hours on Wednesday, reaching $71.04. The company had a trading volume of 417,501 shares, compared to its average volume of 984,300. The company has a debt-to-equity ratio of 2.40, a current ratio of 1.01 and a quick ratio of 1.01. The company has a 50-day moving average price of $69.88 and a 200 day moving average price of $68.74. The firm has a market cap of $18.64 billion, a price-to-earnings ratio of 102.96, a P/E/G ratio of 1.19 and a beta of 0.68. Ryan Specialty Holdings, Inc. has a 12-month low of $52.34 and a 12-month high of $77.16.

Ryan Specialty (NYSE:RYAN - Get Free Report) last posted its earnings results on Thursday, May 1st. The company reported $0.39 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.39. The firm had revenue of $690.17 million for the quarter, compared to analysts' expectations of $680.80 million. Ryan Specialty had a return on equity of 48.01% and a net margin of 9.14%. The business's revenue was up 25.0% compared to the same quarter last year. During the same period in the previous year, the firm earned $0.35 earnings per share. Equities analysts forecast that Ryan Specialty Holdings, Inc. will post 2.29 earnings per share for the current year.

Ryan Specialty Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Tuesday, May 27th. Shareholders of record on Tuesday, May 13th were issued a $0.12 dividend. This represents a $0.48 annualized dividend and a yield of 0.68%. The ex-dividend date was Tuesday, May 13th. Ryan Specialty's dividend payout ratio (DPR) is 141.18%.

Ryan Specialty Company Profile

(Free Report)

Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.

See Also

Institutional Ownership by Quarter for Ryan Specialty (NYSE:RYAN)

Should You Invest $1,000 in Ryan Specialty Right Now?

Before you consider Ryan Specialty, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ryan Specialty wasn't on the list.

While Ryan Specialty currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 AI Stocks to Invest in Today: Capitalizing on AI and Tech Trends in 2025 Cover

Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Top 3 Defense Stocks to Profit From $175 Billion Golden Dome
Top 5 Stocks for June: AI Picks That Aren’t NVIDIA
This Unique Robotaxi Play Could Deliver 10X Returns

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines